dc.contributor.author | Dowsett, M | |
dc.contributor.author | A'Hern, R | |
dc.contributor.author | Salter, J | |
dc.contributor.author | Zabaglo, L | |
dc.contributor.author | Smith, IE | |
dc.date.accessioned | 2018-07-13T11:06:56Z | |
dc.date.issued | 2009-01-01 | |
dc.identifier.citation | Breast cancer research : BCR, 2009, 11 Suppl 3 pp. S15 - ? | |
dc.identifier.issn | 1465-5411 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/2060 | |
dc.identifier.eissn | 1465-542X | |
dc.identifier.doi | 10.1186/bcr2434 | |
dc.format | Print-Electronic | |
dc.format.extent | S15 - ? | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | BMC | |
dc.subject | Humans | |
dc.subject | Breast Neoplasms | |
dc.subject | Ki-67 Antigen | |
dc.subject | Prognosis | |
dc.subject | Treatment Outcome | |
dc.subject | Neoadjuvant Therapy | |
dc.subject | Predictive Value of Tests | |
dc.subject | Time Factors | |
dc.subject | Female | |
dc.title | Who would have thought a single Ki67 measurement would predict long-term outcome? | |
dc.type | Journal Article | |
rioxxterms.versionofrecord | 10.1186/bcr2434 | |
rioxxterms.licenseref.startdate | 2009-01 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | Breast cancer research : BCR | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research/Endocrinology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical Trials & Statistics Unit | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Medicine (RMH Smith Cunningham) | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Medicine (RMH Smith Cunningham)/Medicine (RMH Smith Cunningham) (hon.) | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Endocrinology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Endocrinology/Endocrinology (hon.) | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research/Endocrinology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical Trials & Statistics Unit | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Medicine (RMH Smith Cunningham) | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Medicine (RMH Smith Cunningham)/Medicine (RMH Smith Cunningham) (hon.) | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Endocrinology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Endocrinology/Endocrinology (hon.) | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.publication-status | Published | |
pubs.volume | 11 Suppl 3 | |
pubs.embargo.terms | Not known | |
icr.researchteam | Clinical Trials & Statistics Unit | |
icr.researchteam | Medicine (RMH Smith Cunningham) | |
icr.researchteam | Endocrinology | |
dc.contributor.icrauthor | AHern, Roger | |